PMID: 11920969Mar 29, 2002Paper

Interstitial pulmonary fibrosis after severe exposure to welding fumes

American Journal of Industrial Medicine
U BuerkeH-J Woitowitz

Abstract

Interstitial pulmonary fibrosis (IPF) is reported after long term, severe exposure to welding fumes in poorly ventilated workplaces. Fifteen welders with IPF were examined--13 in our outpatient clinic--from 1990 to 1997. Occupational histories and examinations, lung function analyses, symptoms and clinical findings, histological analyses in 13 patients partly including SEM/EDX-analyses, chest X-rays, chest computed tomographies were conducted. Duration of work as welders was 28 years and the cumulative dose of welding fumes 221 mg/m(3) x years (median). Lung function studies found pattern of restriction or combined restriction-obstruction, lower diffusion capacity, and reduced blood oxygen tension at exercise. Histologically, patchy interstitial fibrosis was noted. Accumulations of particulate matter typically for welding fume were detected. EDX showed increase of iron load and close topographical relationship to welding fume particles embedded in areas of scattered fibrosis. While epidemiological data are limited, it is reasonable to conclude that a causal relationship exists between IPF in welders with long term exposure to high concentrations of welding fumes.

References

May 1, 1978·Archives of Environmental Health·T L GuidottiJ R Smith
Nov 15, 1978·International Archives of Occupational and Environmental Health·P L KalliomäkiM Koponen
Oct 1, 1991·Environmental Research·S K RastogiS Srivastava
Jan 1, 1989·Scandinavian Journal of Social Medicine·O LyngenboN Rossing
Jan 1, 1988·British Journal of Industrial Medicine·A FunahashiK A Siegesmund
Jan 1, 1985·The Journal of the Society of Occupational Medicine·A Zober, D Weltle
Jan 1, 1985·International Archives of Occupational and Environmental Health·J M MurB Meurou-Poncelet
Feb 1, 1983·Journal of Applied Toxicology : JAT·R M SternJ L Abraham
Mar 1, 1981·The American Journal of Medicine·R G CrystalG W Hunninghake
Feb 1, 1995·Regulatory Toxicology and Pharmacology : RTP·G Oberdörster
Oct 1, 1994·American Journal of Respiratory and Critical Care Medicine·D B CoultasR E Sobonya
Sep 1, 1994·American Journal of Respiratory and Critical Care Medicine·K IwaiY Hosoda
Dec 1, 1995·Occupational and Environmental Medicine·O OzdemirH Gürses
Aug 30, 1997·Lancet·M Chan-Yeung, N L Müller
Jul 20, 2000·Der Pathologe·M A Verhoff, K M Müller
Sep 29, 2000·Pneumologie·K M Müller, M A Verhoff
Mar 1, 1993·The European Respiratory Journal·P H QuanjerJ C Yernault

❮ Previous
Next ❯

Citations

Jan 9, 2009·Mucosal Immunology·M S Wilson, T A Wynn
Dec 19, 2003·Journal of Toxicology and Environmental Health. Part a·James M AntoniniJenny R Roberts
Jul 27, 2007·Journal of Toxicology and Environmental Health. Part a·Kyung Taek RimIl Je Yu
Jun 27, 2013·The Annals of Occupational Hygiene·James M AntoniniRobert R Mercer
Jan 6, 2009·Occupational Medicine·Pushpa Jayawardana, Chrishantha Abeysena
Oct 23, 2008·The American Journal of the Medical Sciences·Rajesh R PatelJay H Ryu
Jul 15, 2015·Occupational Medicine·M P Cosgrove
Oct 12, 2004·Toxicology Letters·Il Je YuKwang Jong Kim
Oct 30, 2008·Journal of Immunotoxicology·Mary HassaniAndrij Holian
May 28, 2003·American Journal of Industrial Medicine·John M DementKnut Ringen
May 13, 2006·American Journal of Industrial Medicine·Jiin-Chyuan John LuoWu-Shiun Shen
Jul 11, 2007·American Journal of Industrial Medicine·Nicola MurgiaGiuseppe Abbritti
Oct 31, 2007·Journal of Environmental Monitoring : JEM·A Dale Marcy, Pamela L Drake
May 16, 2020·Diagnostic Cytopathology·Liheng ZhengKeyu Liu
Aug 10, 2020·Journal of Occupational and Environmental Medicine·Mevlüt KarataşTürkan Nadir Öziş
Mar 20, 2003·American Journal of Industrial Medicine·James M AntoniniDavid A Whaley
Jan 28, 2019·The International Journal of Occupational and Environmental Medicine·Younes MehrifarHamideh Pirami
Sep 6, 2020·Journal of Occupational and Environmental Medicine·Mevlüt KarataşTürkan Nadir Öziş
Dec 3, 2016·Journal of Environmental Science and Health. Part A, Toxic/hazardous Substances & Environmental Engineering·Tadeusz HalatekWojciech Wasowicz
Jan 8, 2019·Archives of Environmental & Occupational Health·Deniz KoksalSevgen Onder
Apr 24, 2021·Annals of Work Exposures and Health·Meghan E DueckBernadette Quémerais
Aug 20, 2019·Mutation Research. Genetic Toxicology and Environmental Mutagenesis·İldeniz AksuNursen Basaran

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.